Implant Sciences (IMX) Sells Certain Non-Strategic Assets; Receives Proceeds of $750K
More News related to IMX
- The Dark Knight: The IMAX Experience Crosses $55 Million
- Implant Sciences (IMX) Receives First Orders From GSA Schedule Contract
- Implant Sciences Receives First Order from GSA Schedule Contract
- IMAX comments on change to 2008 film slate
- Implant Sciences Provides Fiscal 2008 Review
More News related to Corporate News
- A.T. Cross (ATX) Moves to NASDAQ; Continue Trading Under Symbol 'ATX'
- VeraSun Energy (VSE) Announced Startup of Ethanol Biorefinery Located Near Dyersville, Iowa
- General Dynamics (GD) Awarded $34 Million for M1A1 Abrams Tank Upgrades
- Toll (TOL) Loses Bid to Dismiss Securities Fraud Suit -Bloomberg
- Parkway Properties (PKY) Announces Sale of Capitol Center Office Property
Implant Sciences Corporation (AMEX: IMX) today announced the execution of a definitive agreement selling certain assets used in the production of coating medical products.
The Company received gross cash proceeds of approximately $750,000 in connection with this sale.
Implant Sciences Corporation engages in the development and acquisition of technologies using ion implantation and thin film coatings for semiconductor and medical device applications in the United States.
Related Categories
Corporate NewsStocks Mentioned
+0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
